Jaco Botha

Effect of Aliskiren on Postdischarge Mortality and Heart Failure Readmissions Among Patients Hospitalized for Heart Failure

Mihai Gheorghiade, Michael Böhm, Stephen J. Greene et al. · JAMA · 2013 · 327 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17

Valsartan Improves Arterial Stiffness in Type 2 Diabetes Independently of Blood Pressure Lowering

Janaka Karalliedde, Andrew H. Smith, Lorenita DeAngelis et al. · Hypertension · 2008 · 142 citations

Pharmacy, Pharmacology, Pharmacotherapy +17

Effect of anti‐ <scp>IL</scp> ‐1β antibody (canakinumab) on insulin secretion rates in impaired glucose tolerance or type 2 diabetes: results of a randomized, placebo‐controlled trial

A Rissanen, Campbell P. Howard, Jaco Botha et al. · Diabetes Obesity and Metabolism · 2012 · 141 citations

Medicine, Endocrinology, Pharmacology +17

Long-Term Antihypertensive Efficacy and Safety of the Oral Direct Renin Inhibitor Aliskiren

Roland E. Schmieder, Thomas Philipp, J Guerediaga et al. · Circulation · 2009 · 133 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Aliskiren for Geriatric Lowering of Systolic Hypertension: a randomized controlled trial

Daniel Duprez, Mark Munger, Jaco Botha et al. · Journal of Human Hypertension · 2009 · 85 citations

Pharmacy, Cardiology, Pharmacotherapy +13